✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

NewAmsterdam Pharma Company N.V.

Common Name
NewAmsterdam Pharma
Country
Netherlands
Sector
Healthcare
Industry
Biotechnology
Employees
100
Ticker
NAMS
Exchange
Nasdaq
Description
NewAmsterdam Pharma Company N.V. is a late-stage biopharmaceutical company focused on developing oral therapies for cardiometabolic diseases, especially patients whose current lipid-lowering treatment...

NewAmsterdam Pharma's Revenues Data

Explore NewAmsterdam Pharma's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
22,503,000a
45,563,000a
14,090,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind NewAmsterdam Pharma’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. NewAmsterdam Pharma's 10-K 2025